DENTSPLY SIRONA (XRAY) Could Be 17% Undervalued As Margin Repair Comes Into Focus

DENTSPLY SIRONA (XRAY) has drawn investor attention after a period of mixed share performance, with the stock up over the past 3 months but down over the past month and past year.

At the current share price of US$11.17, DENTSPLY SIRONA has seen short term momentum pick up, with a 7 day share price return of 2.57%. However, the 1 year total shareholder return is down 19.72%, which points to fading longer term sentiment and an ongoing reassessment of risk and growth potential.

Compare DENTSPLY SIRONA's recent pullback with other potential turnaround ideas by scanning our hand picked 19 high quality undiscovered gems, which currently sit off many investors' radars.

So is this latest rebound in DENTSPLY SIRONA a hint that the business is starting to better match its valuation, or mostly a mood shift after a weak year? It is time to test what the current price actually implies.

Most Popular Narrative: 16.6% Undervalued

The most followed narrative currently places DENTSPLY SIRONA's fair value at $13.40, which sits above the last close at $11.17 and frames today's discount.

DENTSPLY SIRONA is leveraging the increasing global demand for advanced dental care, driven by an aging population and rising middle class in emerging markets, by ramping up investments in product innovation and tailored field support, which is expected to accelerate international revenue growth over the long term.

The company's continued expansion of digital dentistry platforms (such as DS Core) and emphasis on integrated software and hardware solutions aim to capture higher-margin recurring revenues as dental practices adopt digital workflows, supporting sustainable improvements in net margins and earnings.

Read the complete narrative.

Want to see what sits behind that fair value for DENTSPLY SIRONA? The narrative leans heavily on margin repair, steadier revenue, and a future earnings profile that must justify a higher implied multiple.

Result: Fair Value of $13.40 (UNDERVALUED)

Have a read of the narrative in full and understand what's behind the forecasts.

However, DENTSPLY SIRONA still faces pressure from declining global sales and tariff related cost headwinds, which could undermine the margin repair story that investors are watching.

Find out about the key risks to this DENTSPLY SIRONA narrative.

Next Steps

If the mixed sentiment around DENTSPLY SIRONA has you undecided, consider reviewing the details to evaluate the potential rewards for yourself. Start by checking the 4 key rewards.

Looking for more investment ideas beyond DENTSPLY SIRONA?

If DENTSPLY SIRONA has you thinking more broadly about opportunities, use the Simply Wall Street Screener to filter for stocks that better fit your goals and risk comfort.

• Target potential mispricing by scanning our curated set of 45 high quality undervalued stocks, so you do not overlook stocks that the market might be pricing cautiously.
• Strengthen your focus on capital preservation by reviewing a 74 resilient stocks with low risk scores, where lower risk scores can help support a more resilient portfolio.
• Hunt for lesser known opportunities by checking a 19 high quality undiscovered gems, before wider attention narrows the potential gap in expectations.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com